Clinical Trials Directory

Trials / Completed

CompletedNCT05006378

Effect of Chamomile Intake on Blood Coagulation Tests in Healthy Volunteers

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Stony Brook University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

Chamomile may possess anticoagulant effects based on the presence of coumarin-like compounds within the flower. This randomized, placebo-controlled complete crossover study will investigate the impact of chamomile ingestion on coagulation.

Detailed description

Subjects will be enrolled into three groups in a crossover fashion upon obtaining written informed consent. Baseline laboratory screening assays of anticoagulation will be obtained. The three intervention groups include (1) chamomile tea intake, (2) chamomile extract intake and (3) placebo capsules. Subjects will consume the chamomile or placebo preparations for one week and partake in a one-week washout period between interventions. Screening assays of coagulation will be obtained immediately before and after each intervention week.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTChamomile TeaChamomile tea bags consumed by subjects as described in study arms section.
DIETARY_SUPPLEMENTChamomile Extract CapsuleChamomile extract capsules consumed by subjects as described in "Experimental: Chamomile Extract Capsule" study arms section.
DIETARY_SUPPLEMENTPlacebo CapsulePlacebo capsules consumed by subjects as described in "Placebo Comparator" study arms section.

Timeline

Start date
2021-08-31
Primary completion
2022-01-19
Completion
2022-01-19
First posted
2021-08-16
Last updated
2022-02-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05006378. Inclusion in this directory is not an endorsement.